Follow
James Paul Quinn, Ph.D.
James Paul Quinn, Ph.D.
Research Fellow in Neurology, MGH
Verified email at mgh.harvard.edu - Homepage
Title
Cited by
Cited by
Year
Tau proteolysis in the pathogenesis of tauopathies: neurotoxic fragments and novel biomarkers
JP Quinn, NJ Corbett, KAB Kellett, NM Hooper
Journal of Alzheimer's Disease 63 (1), 13-33, 2018
1592018
The involvement of tau in nucleolar transcription and the stress response
MB Maina, LJ Bailey, S Wagih, L Biasetti, SJ Pollack, JP Quinn, ...
Acta neuropathologica communications 6, 1-13, 2018
902018
VGF as a biomarker and therapeutic target in neurodegenerative and psychiatric diseases
JP Quinn, SE Kandigian, BA Trombetta, SE Arnold, BC Carlyle
Brain communications 3 (4), fcab261, 2021
452021
Increased levels of the synaptic proteins PSD-95, SNAP-25, and Neurogranin in the cerebrospinal fluid of patients with Alzheimer’s Disease
SEA Pia Kivisäkk, Becky C Carlyle, Thadryan Sweeney, James P Quinn ...
Alzheimer's Research and Therapy, 2022
33*2022
Responses to 10 common criticisms of anti-racism action in STEMM
ML Gosztyla, L Kwong, NA Murray, CE Williams, N Behnke, P Curry, ...
PLoS Computational Biology 17 (7), e1009141, 2021
292021
Tau diagnostics and clinical studies
I Gozes, G Höglinger, JP Quinn, NM Hooper, K Höglund
Journal of Molecular Neuroscience 63, 123-130, 2017
112017
Cerebrospinal fluid and brain proteoforms of the granin neuropeptide family in alzheimer’s disease
JP Quinn, EC Ethier, A Novielli, A Malone, CE Ramirez, L Salloum, ...
Journal of the American Society for Mass Spectrometry 34 (4), 649-667, 2023
72023
Age-Dependent Increase in Tau Phosphorylation at Serine 396 in Huntington’s Disease Prefrontal Cortex
T Petrozziello, S Huntress, A Castillo-Torres, J Quinn, T Connors, C Auger, ...
Journal of Huntington's Disease 12 (3), 267-281, 2023
22023
Characterization of novel neuropeptide proteolytic processing involved in dementia pathophysiology
EC Ethier, JP Quinn, SE Kandigian, BA Trombetta, SE Arnold, BC Carlyle
Alzheimer's & Dementia 17, e058553, 2021
2021
Characterizing proteoforms of the granin family of neuropeptides in dementia pathophysiology
JP Quinn, EC Ethier, SE Kandigian, BA Trombetta, SE Arnold, BC Carlyle
Alzheimer's & Dementia 17, e056265, 2021
2021
Characterizing chromogranin and secretogranin proteoforms in dementia pathophysiology: Molecular and cell biology/neurodegeneration and neuroprotection
JP Quinn, SE Kandigian, BA Trombetta, SE Arnold, BC Carlyle
Alzheimer's & Dementia 16, e044624, 2020
2020
Characterizing chromogranin and secretogranin proteoforms in dementia pathophysiology
JP Quinn, SE Kandigian, BA Trombetta, SE Arnold, BC Carlyle
2020 Alzheimer's Association International Conference, 2020
2020
P4‐524: PROTEOLYTIC CLEAVAGE OF TAU IN CORTICOBASAL DEGENERATION AND PROGRESSIVE SUPRANUCLEAR PALSY PATHOGENESIS
JP Quinn, T Katsinelos, NJ Corbett, W Nickel, KA Kellett, NM Hooper
Alzheimer's & Dementia 15, P1514-P1515, 2019
2019
O1‐06‐06: PROTEOLYTIC CLEAVAGE OF TAU IN DEMENTIA PATHOGENESIS
JP Quinn, NJ Corbett, KA Kellett, NM Hooper
Alzheimer's & Dementia 14 (7S_Part_4), P232-P232, 2018
2018
P3‐230: IDENTIFICATION OF A PLASMA PROTEIN SIGNATURE FOR ALZHEIMER'S DISEASE
JP Quinn, KA Kellett, NJ Corbett, DC Lee, B Geary, AD Whetton, ...
Alzheimer's & Dementia 14 (7S_Part_22), P1159-P1159, 2018
2018
Tau Proteolysis–Mechanisms and Relevance for Tauopathies
JP Quinn
PQDT-Global, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–16